Finasteride clears from your bloodstream relatively quickly, with an elimination half-life of roughly five to seven hours, meaning the drug itself is essentially gone within a day or two of your last pill. But that number is misleading if what you really want to know is how long finasteride keeps affecting your body. Because of the way the drug binds to an enzyme in your tissues, its biological effects last far longer than its presence in blood, and the timeline for things like DHT suppression, hair loss reversal, and even blood donation eligibility stretches from days to months depending on what you’re measuring.
Why the Drug Leaves Fast but Its Effects Stick Around
The terminal elimination half-life of finasteride is between about 4.7 and 7.1 hours, with some sources putting the average closer to six to eight hours.1PubMed. Clinical pharmacokinetics and pharmacodynamics of finasteride2Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Finasteride: The First 5α‐Reductase Inhibitor After about five half-lives (roughly 30 to 40 hours), the concentration of finasteride in your blood drops to negligible levels. If clearance were the whole story, the answer would be simple: gone in about two days.
The complication is that finasteride doesn’t just float around in your plasma doing its job. It works by binding to the 5-alpha-reductase enzyme with extremely high affinity, forming a complex that effectively takes the enzyme out of commission. Even after the free drug in your blood has been metabolized and excreted, those enzyme-drug complexes in your tissues are still sitting there, preventing the conversion of testosterone to DHT. A single dose of finasteride can suppress serum DHT levels for up to four days, far longer than you’d predict from the half-life alone.1PubMed. Clinical pharmacokinetics and pharmacodynamics of finasteride Your body has to manufacture new enzyme to replace the bound-up copies, and that takes time.
This distinction between drug clearance and biological effect matters for nearly every practical question about finasteride timing, from when side effects might fade after stopping to how long you need to wait before donating blood.
How Long DHT Stays Suppressed After Your Last Dose
When you take finasteride daily at the standard 1 mg dose for hair loss, your serum DHT drops significantly. After you stop, DHT doesn’t bounce back overnight. Because the enzyme-drug complexes in tissues need to be replaced by freshly synthesized enzyme, DHT levels climb back toward their pre-treatment baseline gradually over several weeks.
The general clinical consensus, reflected in blood donation guidelines and prescribing information, is that DHT levels in the blood normalize within roughly a month of stopping. Scalp tissue, where finasteride accumulates and where its effect on hair follicles matters most, follows a similar timeline. After about a month off the drug, local DHT levels in the scalp are expected to return to their pre-treatment state, and the biochemical protection finasteride provided to hair follicles effectively ends.
There’s also a slow-accumulation effect worth knowing about. Despite the short half-life, taking finasteride daily leads to gradual buildup in tissues over time.1PubMed. Clinical pharmacokinetics and pharmacodynamics of finasteride Someone who has been on the drug for years has more of it distributed in tissues than someone who just started, which may mean the biological effects take slightly longer to fully wear off in long-term users. The pharmacokinetics literature doesn’t give a precise number for how much this extends the DHT suppression timeline, but the blood-donation deferral period of one month is calibrated conservatively enough to account for it.
Blood Donation Deferral and What It Tells You
If you’re taking finasteride and want to donate blood, the standard recommendation is to wait at least one month after your last dose. This deferral exists because finasteride can cause birth defects in male fetuses, and donated blood could end up being transfused to a pregnant person. The one-month window is designed to ensure that finasteride concentrations in donated blood fall below any level that could pose a risk.3Georgetown Medical Review. Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
For comparison, dutasteride, a related drug that blocks both forms of the 5-alpha-reductase enzyme, has a deferral period of six months because it has a much longer half-life and lingers in the body far longer. The one-month window for finasteride is a useful benchmark: it’s the period regulators have determined is long enough for the drug to drop below a biologically meaningful concentration in blood.
Real-world testing of blood donors bears this out. A study that analyzed stored blood samples from donors who had taken teratogenic medications found that finasteride was detectable in some specimens, and in one case was detectable beyond the recommended deferral period.4PubMed. Blood donors on teratogenic drugs and donor deferral periods in a clinical situation That finding didn’t lead to a change in policy, but it’s a reminder that the one-month guideline is a population-level safety margin, not a guarantee that every individual will be at zero by day 30.
Urinary Detection Windows
Finasteride is on the World Anti-Doping Agency’s prohibited list because of its ability to mask steroid use (by altering the testosterone-to-epitestosterone ratio in urine). So if you’re an athlete subject to drug testing, the detection window is a real concern.
The drug’s main urinary metabolite, carboxy-finasteride, is the marker anti-doping labs look for. After a single oral dose of 5 mg, this metabolite has been detected in urine for up to about 49 hours.5Acta Pharmaceutica Sinica B. Screening and confirmation methods of the major urinary metabolite of finasteride–carboxy-finasteride by liquid chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry That’s roughly two days. With daily use, the detection window would extend somewhat because of accumulation, but the urinary half-life is still much shorter than the drug’s biological effect timeline. Urine clears finasteride traces on the scale of days, not weeks.
Keep in mind that a 5 mg dose is the prostate-treatment dose, five times larger than the standard hair-loss dose. At 1 mg, the detection window in urine is shorter, though exact published timelines for the lower dose are sparse. If you’re subject to anti-doping testing, the safest approach is to declare finasteride use and get a therapeutic use exemption rather than trying to time your last dose.
Topical Finasteride Changes the Equation
Topical finasteride formulations, which are applied directly to the scalp, deliver the drug locally while dramatically reducing how much gets into your bloodstream. This changes the “how long does it stay in your system” question in a meaningful way.
In animal studies, certain topical formulations produced no detectable finasteride in plasma at all, even after repeated application, while still depositing the drug in the skin near hair follicles.6PubMed. Topical formulations containing finasteride. Part I: in vitro permeation/penetration study and in vivo pharmacokinetics in hairless rat Human studies show some systemic absorption, but peak blood levels from a 0.25% topical spray are dramatically lower than from a 1 mg oral tablet. Computer simulations comparing the two routes found that topical application at 0.25% produced peak plasma concentrations roughly 100-fold lower than oral dosing.7Annales Pharmaceutiques Françaises. Topical finasteride dose evaluation for treatment of androgenetic alopecia using computer simulations
A phase I pharmacokinetic study in men using a 0.25% topical spray found peak plasma concentrations in the low picograms-per-milliliter range, with a half-life after multiple doses of roughly 23 hours, longer than the oral half-life but reflecting slower absorption from the skin depot rather than higher systemic exposure.8PubMed. The Pharmacokinetics of Topical Finasteride 0.25% Spray in Chinese Adult Male Volunteers with Androgenic Alopecia: A Phase I Study In practical terms, topical finasteride clears from your blood faster in absolute concentration terms because so little gets there to begin with. For anyone concerned about systemic exposure and clearance, topical formulations represent a meaningfully different pharmacokinetic profile.
What Happens to Your Hair After Stopping
This is where the “how long does it stay in your system” question runs into a longer and more frustrating timeline. Even though finasteride itself and its DHT-suppressing effects are gone within roughly a month, the visible consequences of stopping unfold over one to three years.
A study tracking men who stopped finasteride after maintaining stable hair growth found that the first 12 months off the drug looked relatively uneventful. Hair that had been in an active growth phase when finasteride was discontinued continued growing through its normal cycle. The trouble started after that first year, when the hair follicles that had been kept productive by DHT suppression began miniaturizing without it. By 30 months off the drug, 94% of previously healthy terminal hairs had miniaturized and become unproductive.9PubMed. Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a “drug dependency” and a post-finasteride “rebound effect”
The researchers described this as a “rebound effect” and characterized the responding follicles as effectively “finasteride dependent.” The delay is explained by the hair growth cycle itself: a hair that entered its growth phase while you were still taking finasteride will continue growing for months before it sheds and the follicle has to start fresh in the now-unprotected hormonal environment. So while finasteride leaves your system in weeks, you won’t see the full hair-loss consequences of stopping for a year or more. For many people, this creates a false sense of security during those first few months off the drug.
Factors That Can Speed Up or Slow Down Clearance
Finasteride is metabolized primarily by an enzyme in the liver called CYP3A4, the same enzyme responsible for breaking down a large number of common medications. Anything that significantly revs up or slows down this enzyme’s activity will change how quickly finasteride leaves your system.
The best-studied example is St. John’s wort, a widely available herbal supplement. Two weeks of St. John’s wort use significantly reduced finasteride’s plasma exposure, including lower peak concentration and shorter half-life, by inducing CYP3A4 to work harder.10European Journal of Pharmaceutical Sciences. The effect of St. John’s wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men In other words, taking St. John’s wort alongside finasteride causes your body to chew through the drug faster, potentially reducing its effectiveness. Other CYP3A4 inducers, like certain anti-seizure medications, could theoretically do the same, though specific studies with finasteride haven’t been published for most of them.
On the flip side, strong CYP3A4 inhibitors, such as ketoconazole (an antifungal), grapefruit juice in large quantities, and certain HIV medications, could slow finasteride metabolism and keep blood levels elevated longer. The clinical significance of these interactions is generally considered modest for finasteride because of the drug’s already short half-life and wide therapeutic window, but they’re worth knowing about if you’re trying to time clearance precisely.
Age also plays a role. Older adults clear finasteride more slowly. The 5 mg dose used for prostate treatment was originally studied in older men, and clearance rates in that population tend to be at the longer end of the half-life range. Liver function matters too, as you’d expect for a drug that depends on hepatic metabolism. Someone with significant liver impairment would clear the drug more slowly, though finasteride is not typically considered a high-risk medication in mild-to-moderate liver disease.
The Dose Question
Finasteride comes in two dose levels for its two approved uses: 1 mg daily for hair loss and 5 mg daily for benign prostatic hyperplasia. The pharmacokinetics data shows that the elimination half-life is roughly the same regardless of dose, meaning a 5 mg pill doesn’t stay in your system five times longer than a 1 mg pill. What changes is the peak concentration and overall exposure. A larger dose means more drug in your blood at any given point, which translates to a slightly longer time until levels drop below detection thresholds, but the difference is a matter of hours, not days.
Interestingly, the dose-response curve for DHT suppression is quite flat above a certain point. Doses below about 0.5 mg per day don’t suppress DHT very effectively, while going above 5 mg per day provides little additional benefit.1PubMed. Clinical pharmacokinetics and pharmacodynamics of finasteride This plateau is another reflection of the enzyme-binding mechanism: once you’ve dosed enough to occupy most of the available 5-alpha-reductase enzymes, extra drug just circulates without doing much extra work. After stopping, the biological effect from either dose resolves on roughly the same timeline because the rate-limiting step is enzyme regeneration, not drug elimination.
Post-Finasteride Syndrome and Lingering Effects
A small number of people who stop finasteride report side effects that persist long after the drug has left their system. These include sexual symptoms like reduced libido and erectile dysfunction, along with mood changes, cognitive complaints, and fatigue. The phenomenon has been labeled post-finasteride syndrome.11PubMed Central. Post-finasteride syndrome12Neurobiology of Stress. Post-finasteride syndrome: An emerging clinical problem
The definition used in the literature is symptoms persisting for at least three months after discontinuation, which is well beyond any pharmacokinetic timeline for the drug itself. The cause remains unclear. Proposed mechanisms involve lasting changes to neurosteroid levels, androgen receptor sensitivity, or epigenetic alterations in hormone-responsive tissues, but none of these has been definitively established.13International Journal of Impotence Research. The post-finasteride syndrome: possible etiological mechanisms and symptoms Current research cannot definitively confirm or refute the syndrome as a distinct clinical entity, and there is no established treatment for it.11PubMed Central. Post-finasteride syndrome
Whatever the underlying mechanism, post-finasteride syndrome represents a situation where the question “how long does finasteride stay in your system” misses the point entirely. The drug is gone, but something it changed during its stay isn’t reverting to normal. For most people, side effects that occur during treatment resolve within weeks to a couple of months after stopping. But for those who experience persistent symptoms, the timeline is measured in months to years, and the honest answer from the medical community is that it isn’t well understood yet. If you develop new or worsening symptoms after stopping finasteride and they haven’t improved after a few months, that’s worth bringing to your doctor specifically, rather than waiting for the drug to “clear” because pharmacokinetically it already has.
Finasteride and Pregnancy Exposure Timelines
The most practically consequential clearance question for many people involves pregnancy. Finasteride is classified as a pregnancy risk because it can interfere with normal genital development in male fetuses. This concern applies not just to women who might accidentally take the drug, but to male partners whose semen could contain trace amounts of finasteride.
Semen concentrations of finasteride are extremely low during treatment, estimated at a fraction of a percent of the blood concentration, and are considered too small to pose a realistic risk to a fetus through vaginal absorption. Prescribing guidelines generally don’t require men to stop finasteride before trying to conceive, though some physicians recommend a washout period of one to three months out of an abundance of caution. The one-month blood donation deferral reflects the same concern through a different exposure route: ensuring the drug is undetectable before blood could reach a pregnant recipient.3Georgetown Medical Review. Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
Pregnant women or women who could become pregnant are advised not to handle crushed or broken finasteride tablets, because the drug can be absorbed through the skin. Intact tablets are coated to prevent contact absorption during normal handling. This skin-absorption risk has its own clearance implications: accidental dermal exposure produces much lower systemic levels than oral ingestion, but even small amounts are considered potentially dangerous during pregnancy because the drug’s mechanism of action directly targets a pathway critical to fetal development.